2Rodriguez JC, Ruiz M, Lopez M, et al. In vitro activity of moxifloxacin,levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis[J]. Int J Antimicro Agents ,2002,20(6) :464-7. 被引量：1
3Behra-Miellet J ,Dubreuil L,Jumas-Bilak E. Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciproflocaxin, clidamycin, metronidazole and beta-lactams[J ]. Int J Antimicrob Agents, 2002,20(5) : 366-74. 被引量：1
5Lode H, Garau J. Improving care for patients with respiratory tract infections[J] . J Chemother ,2002,14 ( Suppl 2):22-8. 被引量：1
6Bristor-Myer Squibb. Gatifloxacin (Tequin) :An advanced generation quinolone for the treatment of selected infectious diseases [M] .Glenview: Physicians Scientists Publishing CO, INC, 2000. 47. 被引量：1
7Wish R, Honeybourne D. Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract[J]. European Respir J, 1999, 14 ( 1 ): 221. 被引量：1
8Ball P, Wilson R, Mandell L, et al. Efficacy of gemifloxacin in acute exacerbations of chronic bronchitis: a randomized, double-blind comparison with trovafloxacin[J]. J Chemother 2001,13 (3):288. 被引量：1
9Tillotson G, Zhao X, Drilica K. Fluoroquinolones as pneumococcal therapy: Closing the barn door before the horse escapes [J]. The Lancet infections Disea, 2001, 1(3): 145. 被引量：1
10Drugeon HB, Juvin ME, Bryskier. Relative potential for selection of fluoroquinolone-resistant streptoccus pneumoniae strains by levofloxacin: Comparison with Ciprofloxacin, sparfloxacin and ofloxacin [J]. J Antimicrob Chemother, 1999, 43 (Suppl)C55. 被引量：1
